Revenue, last quarter
$43.3M
−9.6% vs same quarter last year
Net income
$407K
−95% vs same quarter last year
EPS, diluted
$0.01
−95.5% vs same quarter last year
Operating cash flow
$3.7M
−73.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $192.2M | $27M |
| FY24 | $197.2M | $3.2M |
| FY23 | $185.4M | $3.3M |
| FY22 | $165M | −$969K |
| FY21 | $139.4M | $11.1M |
| FY20 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 18.5% | 14.1% |
| FY24 | 16% | 1.6% |
| FY23 | 15.5% | 1.8% |
| FY22 | −36.8% | −0.6% |
| FY21 | 24.8% | 8% |
| FY20 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $30.2M |
| FY24 | $38.8M |
| FY23 | $26.5M |
| FY22 | −$9.5M |
| FY21 | $32.3M |
| FY20 | - |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $1.7M | $3.4M |
| FY24 | $4.7M | $5.6M |
| FY23 | $8.7M | - |
| FY22 | $12.9M | - |
| FY21 | $11.4M | - |
| FY20 | - | - |
- biote Corp.
- Healthcare median
Show the numbers
| Year | biote Corp. | Healthcare median |
|---|---|---|
| FY25 | 14.1% | −30.6% |
| FY24 | 1.6% | −47% |
| FY23 | 1.8% | −58% |
| FY22 | −0.6% | −80.4% |
| FY21 | 8% | −71.8% |
| FY20 | - | −62.2% |